Viridian Therapeutics
VRDN
VRDN
59 hedge funds and large institutions have $62.7M invested in Viridian Therapeutics in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+8
Holders Change %
+15.69%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.47M |
| 2 |
6CM
683 Capital Management
New York
|
+$3.51M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.86M |
| 4 |
AG
Artal Group
Luxembourg
|
+$2.8M |
| 5 |
BlackRock
New York
|
+$1.64M |
